The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.

Date
2016
Author
ABACI, Ayhan
Siklar, Zeynep
Genens, Mikayir
Bundak, Ruveyde
Cetinkaya, Semra
ATAY, Zeynep
Turan, Serap
Kara, Cengiz
Yilmaz, Gulay Can
Akyurek, Nesibe
Celmeli, Gamze
Sari, Erkan
BOLU, Semih
Korkmaz, Huseyin Anil
SIMSEK, Enver
CATLI, Gonul
Buyukinan, Muammer
CAYIR, Atilla
Isguven, Pinar
Ozgen, Tolga
Hatipoglu, Nihal
Elhan, Atilla Halil
Berberoglu, Merih
Evliyaoglu, Olcay
Erdeve, Senay Savas
Aycan, Zehra
Darendeliler, Fatma Feyza
Bas, Firdevs
Guven, Ayla
Poyrazoglu, Sukran
Abali, Saygın
Metadata
Show full item record
Abstract
Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking manifestation. Optimal growth hormone (GH) treatment for NS is still controversial. In this study, using a nationwide registration system, we aimed to evaluate the growth characteristics and the clinical features of NS patients in Turkey and their growth response to GH treatment.
URI
http://hdl.handle.net/20.500.12627/38256
https://doi.org/10.4274/jcrpe.3013
Collections